Plaque psoriasis and psoriatic arthritis: trials to watch in 2022
Four Phase II and III trials in plaque psoriasis or psoriatic arthritis have results expected in 2H 2022, and five…
By
Dermatology
Latest in
Dermatology
Union begins enrolment in Phase IIb atopic dermatitis trial
The company plans to carry out the trial in centres in Europe and the US.
Kintor concludes Phase II androgenetic alopecia trial enrolment
The trial’s primary endpoint will be the change in non-vellus target area hair counts at week 24 from baseline.
Lynk doses first subject in Phase I trial of plaque psoriasis drug
In preclinical experiments, LNK01004 demonstrated good safety and efficacy.
InMed enrols first adolescent in Phase II epidermolysis bullosa trial
The trial will assess the safety of INM-755 as well as its initial efficacy to treat symptoms and heal wounds…
Pipeline Moves: Phase II essential tremor trial completes, advancement prospects jump
Clinical Trials Arena team also look into trials in glioblastoma multiforme, open-angle glaucoma, and hives.
By
Dice Therapeutics concludes enrolment of Phase I trial studying psoriasis asset
A Phase Ic (proof-of-concept) part of the trial will be carried out in patients with psoriasis.
Aristea contemplates Phase III design for rare skin disease drug
As Aristea develops a palmoplantar pustulosis treatment, US and European regulators indicate different primary endpoint preferences.
By